4//SEC Filing
Cranston Lynda Sarah 4
Accession 0000905718-19-000761
CIK 0001498382other
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:36 PM ET
Size
7.8 KB
Accession
0000905718-19-000761
Insider Transaction Report
Form 4
Cranston Lynda Sarah
Director
Transactions
- Award
Options (Right to Buy)
2019-09-05+35,433→ 35,433 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (35,433 underlying) - Award
Options (Right to Buy)
2019-09-05+39,567→ 39,567 totalExercise: $0.61Exp: 2029-09-05→ Common Stock (39,567 underlying)
Footnotes (2)
- [F1]Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019.
- [F2]The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001633660
Filing Metadata
- Form type
- 4
- Filed
- Sep 8, 8:00 PM ET
- Accepted
- Sep 9, 4:36 PM ET
- Size
- 7.8 KB